Novel actions of methylene blue (1993)

Peer-Reviewed Study · B. Mayer, F. Brunner, K. Schmidt · November 1993

B. Mayer et al., 1993-11: Laboratory report that methylene blue inhibits purified NO synthase at 5.3 micromolar (9.2 micromolar with superoxide dismutase) while purified soluble guanylyl cyclase needs about 60 micromolar for half-maximal inhibition and 1 mM for about 70 percent, concluding that methylene blue is only a poor inhibitor of soluble guanylyl cyclase and acts primarily on NO synthase.

Our data indicate that methylene blue is only a poor inhibitor of soluble guanylyl cyclase.

Abstract

B. Mayer et al., 1993-11: Laboratory report that methylene blue inhibits purified NO synthase at 5.3 micromolar (9.2 micromolar with superoxide dismutase) while purified soluble guanylyl cyclase needs about 60 micromolar for half-maximal inhibition and 1 mM for about 70 percent, concluding that methylene blue is only a poor inhibitor of soluble guanylyl cyclase and acts primarily on NO synthase. Laboratory study (purified enzymes, isolated vessels). Country: Austria (University of Graz). Near-duplicate publication of MTJ-22 in a different journal – both are recorded because the second is what cardiology and shock literature cites. Concentrations as in MTJ-22. Route: in vitro. Funder/conflicts: not captured in the PubMed record. Comparator: untreated preparations. Study type: lab.